← All trials
NCT05317195
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 15, 2022
- Primary completion
- May 7, 2022
- Completion date
- Aug 18, 2022
- First posted
- Apr 7, 2022
- Last posted
- Aug 31, 2022
- Enrollment
- 24
- Arms / groups
- 6 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Philip MorrisLead sponsor
- CelerionOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.